Save mRNA Cancer Research Breakthroughs

The Issue
mRNA technology—best known for powering COVID-19 vaccines—is now offering new hope in the fight against cancer. Researchers are developing mRNA-based vaccines and treatments for some of the hardest-to-treat cancers, including breast, ovarian, and pancreatic cancer. For many patients and families, this research represents not just science, but the possibility of more time, more hope, and more lives saved.

But right now, that hope is in danger. The Trump administration has cut federal funding for mRNA cancer research, stalling dozens of promising clinical trials. Treatments that could have been available within years risk being delayed indefinitely—or shelved entirely.

This decision doesn’t just set science back—it devastates patients, families, and communities who have been waiting for breakthroughs. It also threatens America’s global leadership in medical innovation at the very moment when the world is watching.

President Trump has spoken about curing cancer. Restoring funding for mRNA research is how we make that promise real.

We Call On President Trump and Congress to:

• Immediately restore and expand funding for mRNA cancer research.
• Prioritize clinical trials already underway, ensuring they are not abandoned midstream.
• Recommit to supporting the scientists and institutions driving lifesaving innovation.

This is not about politics—it’s about people. It’s about giving patients real hope, advancing medicine, and saving lives. America cannot afford to abandon mRNA cancer research now.